Peptides: Medical Breakthrough or Risky Shortcut?

About this episode

Peptides, supplements, GLP-1 weight-loss drugs, NAD, IV drips, and “longevity stacks” are everywhere. But how much do people really know about what they are putting into their bodies? Dr. Jared Ament and Dr. Jon Kanevsky join this new episode of Real Talk to explain the potential benefits of peptides, why so many Americans are experimenting with them, and why the gray-market peptide industry can be risky. They break down FDA approval, third-party testing, China-based sourcing, growth hormone peptides, Ozempic, retatrutide, creatine, NAD, and the role of AI in helping patients research their own health. We also discuss why good medicine requires both curiosity and humility. This episode is part of a series of medical interviews. The views expressed by the physicians are their own and do not necessarily reflect the views of the host or PragerU. This episode is for informational purposes only and does not constitute medical advice. Follow Marissa on social: Instagram: https://www.instagram.com/marissastreit/ Facebook: https://www.facebook.com/marissastreitofficial/ Twitter/X: https://x.com/marissastreit/ TikTok: https://www.tiktok.com/@marissastreit LinkedIn: https://www.linkedin.com/in/marissastreit/ PragerU: https://www.prageru.com/shows/real-talk/ PragerU Español: https://www.youtube.com/@esPragerU Listen to Real Talk with Marissa Streit on Spotify and Apple Podcasts New episodes drop every Wednesday! Spotify: https://l.prageru.com/407PQ51 Apple Podcasts: https://l.prageru.com/4u4hX2B Learn more about your ad choices. Visit megaphone.fm/adchoices